SCHEMBL3654476

SCHEMBL3654476

COc1ccc(F)cc1C(C)(CC(C)(O)Cc1cc2cnncc2s1)C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 20/20 0.61
NR3C2 P08235 12/20 0.61
PGR P06401 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL451274 0.89 NR3C1 (0.67) NR3C1NR3C2PGR
SCHEMBL3652847 0.89 NR3C1 (0.78) NR3C1NR3C2PGR
SCHEMBL293471 0.87 NR3C1 (0.79) NR3C1NR3C2PGR
SCHEMBL1932801 0.79 NR3C1 (0.59) NR3C1NR3C2PGR
SCHEMBL291401 0.76 NR3C1 (0.86) NR3C1NR3C2PGR
SCHEMBL292894 0.76 NR3C1 (1.00) NR3C1NR3C2PGR
SCHEMBL4442957 0.76 NR3C1 (0.53) NR3C1NR3C2PGR
SCHEMBL3654089 0.75 NR3C1 (0.57) NR3C1NR3C2PGR
SCHEMBL6908248 0.74 NR3C1 (0.73) NR3C1NR3C2PGR
SCHEMBL291605 0.73 NR3C1 (0.76) NR3C1NR3C2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203160-A1 PHARMACOLOGICAL ADJUNCTIVE TREATMENT ASSOCIATED WITH GLAUCOMA FILTRATION SURGERY Bausch & Lomb Incorporated (US) 2010-07-07 EP disclosed
EP-2190431-A2 COMPOSITIONS COMPRISING A DISSOCIATED GLUCOCORTICOID RECEPTOR AGONIST FOR TREATING OR CONTROLLING ANTERIOR-SEGMENT INFLAMMATION Bausch & Lomb Incorporated (US) 2010-06-02 EP disclosed
WO-2009042377-A1 PHARMACOLOGICAL ADJUNCTIVE TREATMENT ASSOCIATED WITH GLAUCOMA FILTRATION SURGERY BAUSCH & LOMB INCORPORATED (US) 2009-04-02 WO disclosed
WO-2009023471-A2 COMPOSITIONS COMPRISING A DISSOCIATED GLUCOCORTICOID RECEPTOR AGONIST FOR TREATING OR CONTROLLING ANTERIOR-SEGMENT INFLAMMATION BAUSCH & LOMB INCORPORATED (US) 2009-02-19 WO disclosed